Efficacy of Metronomic Vinorelbine in Elderly Patients with Advanced Non-Small-Cell Lung Cancer and Poor Performance Status
Author(s) -
Cemil Bilir,
Serdar Durak,
Bayram Kızılkaya,
İ̇lhan Hacibekiroğlu,
Erdinç Nayır,
Hüseyin Engin
Publication year - 2017
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.24.3486
Subject(s) - vinorelbine , medicine , lung cancer , chemotherapy , oncology , performance status , progressive disease , cancer , surgery , cisplatin
Metronomic chemotherapy-administration of low-dose chemotherapy-allows for a prolonged treatment duration and minimizes toxicity for unfit patients diagnosed with advanced non-small-cell lung cancer (nsclc).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom